Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON49634
NL-OMON49634
Completed
Not Applicable

Measuring Athletes* Risk of Cardiovascular Events - Exercise-Induced Cardiac Troponin Release and Coronary Atherosclerosis in Amateur Athletes - MARC-EXERSCIENCE

Radboud Universitair Medisch Centrum0 sites60 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Radboud Universitair Medisch Centrum
Enrollment
60
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • •\- Participation in MARC\-2 study (so recent information about coronary
  • •atherosclerosis is known).
  • •\- Availability of recent (\<2 years) contrast enhanced coronary CT\-scan data
  • •\- Willingness to be approached for participation in future research (as
  • •indicated on the informed consent form of the MARC\-2 study)
  • •\- Able to perform a ±1\.5 hour exercise test on a bicycle

Exclusion Criteria

  • •\- Unable to give informed consent
  • •\- Presence of a stent in any coronary artery or undergone coronary artery
  • •bypass surgery
  • •\- Not cleared for exercise training by a cardiologist following the MARC\-2
  • •study coronary CT\-scan findings
  • •\- Absolute contra\-indications for an exercise test (as indicated by the
  • •Standard Operating Procedure guidelines of the department of Physiology (see
  • •page 16 of C1 protocol)).
  • •\- Participation in an interventional study targeting cardiovascular health

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Measuring Athletes’ Risk of Cardiovascular Events - Exercise-Induced Cardiac Troponin Release and CoronaryAtherosclerosis in Amateur Athletes
NL-OMON24615Department of Physiology, Radboudumc60
Recruiting
Not Applicable
Measuring Athlete's Risk of Cardiovascular eventsatherosclerosiscoronary artery disease1001108210003216
NL-OMON35520Meander Medisch Centrum300
Not yet recruiting
Not Applicable
Assessment of cardio vascular risk by measurement of carotid intima-media thickness (cIMT) in adult type I Gaucher disease patients.Gaucher disease type Iglucocerebrosidase deficiency10027424
NL-OMON29706Academisch Medisch Centrum140
Active, not recruiting
Phase 1
Study to Determine if The Cardiovascular risk indices in Impaired Glucose Tolerance are similar for Polycystic Ovarian Syndrome, and whether they may be modified by Therapy - Cardiovascular risk in PCOS as compared to impaired glucose toleranceThis is a randomised parallel controlled trial between patients with impaired glucose tolerance and those with polycystic ovarian syndrome. Patients will either be randomised to metformin or Pioglitazone.
EUCTR2005-000435-18-GBniversity of Hull48
Active, not recruiting
Phase 1
Study to Determine if The Cardiovascular risk indices in Type 2 diabetes are similar for Polycystic Ovarian Syndrome, and whether they may be modified by Therapy - Cardiovascular risk in PCOS as compared to type 2 DiabetesThis is a randomised parallel controlled trial between patients with type 2 diabetes and those with polycystic ovarian syndrome. Patients will either be randomised to metformin or Pioglitazone.
EUCTR2005-000461-18-GBniversity of Hull48